Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
January 3, 2020
Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH
Elizabeth M Van Cott, Christelle Orlando, Gary W Moore, et al.
Annals of Intensive Care
|
March 31, 2022
Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study
Richard Fisher, Gary W Moore, Michael J Mitchell, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 19, 2019
Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH
Gary W Moore, Elizabeth M Van Cott, Jacqueline A Cutler, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 14, 2025
Survey on current practice in thrombophilia testing: from phenotype to genotype. Communication from the SSC of the ISTH
Christine Van Laer, Gary W Moore, Rinku Majumder, et al.
Thrombosis and Haemostasis
|
January 12, 2012
Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome
Karen A Breen, Paul Seed, Kiran Parmar, et al.
Thrombosis Research
|
December 10, 2013
Complete prekallikrein deficiency masquerading as a lupus anticoagulant
Gary W Moore, Shirish R Sangle, Robert A Archer, et al.
BMC Nephrology
|
October 4, 2017
The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study
Richard Fisher, Katie Lei, Mike J Mitchell, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 4, 2024
Toward harmonized interpretation of anticardiolipin and anti-β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
Arne Vandevelde, Jean-Christophe Gris, Gary W Moore, et al.
Hereditary Cancer in Clinical Practice
|
May 23, 2022
Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013-2018
Mahip Acharya, Kristin K Zorn, Melinda E Simonson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
December 15, 2015
Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients
Gary W Moore, Aidan P Culhane, James C Maloney, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
Journal of Thrombosis and Haemostasis : JTH
|
January 3, 2020
Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH
Elizabeth M Van Cott, Christelle Orlando, Gary W Moore, et al.
Annals of Intensive Care
|
March 31, 2022
Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study
Richard Fisher, Gary W Moore, Michael J Mitchell, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 19, 2019
Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH
Gary W Moore, Elizabeth M Van Cott, Jacqueline A Cutler, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 14, 2025
Survey on current practice in thrombophilia testing: from phenotype to genotype. Communication from the SSC of the ISTH
Christine Van Laer, Gary W Moore, Rinku Majumder, et al.
Thrombosis and Haemostasis
|
January 12, 2012
Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome
Karen A Breen, Paul Seed, Kiran Parmar, et al.
Thrombosis Research
|
December 10, 2013
Complete prekallikrein deficiency masquerading as a lupus anticoagulant
Gary W Moore, Shirish R Sangle, Robert A Archer, et al.
BMC Nephrology
|
October 4, 2017
The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study
Richard Fisher, Katie Lei, Mike J Mitchell, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 4, 2024
Toward harmonized interpretation of anticardiolipin and anti-β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
Arne Vandevelde, Jean-Christophe Gris, Gary W Moore, et al.
Hereditary Cancer in Clinical Practice
|
May 23, 2022
Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013-2018
Mahip Acharya, Kristin K Zorn, Melinda E Simonson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
December 15, 2015
Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients
Gary W Moore, Aidan P Culhane, James C Maloney, et al.
Page
of 7